Fred Hutchinson

The combination treatment of two or more antihypertensive therapies in patients being treated with ibrutinib can significantly reduce blood pressure, data published in Blood Advances showed.

SAN DIEGO — Patients with relapsed large B-cell lymphoma who achieved a complete remission had a reduced relapse rate and improved PFS with autologous transplant, according to study findings presented at ASH Annual Meeting and Exposition.

The addition of tucatinib to ado-trastuzumab emtansine significantly improved PFS among patients with unresectable locally advanced or metastatic HER2-positive breast cancer, according to study findings.

Novel targeted therapies have become standard treatment for chronic lymphocytic leukemia due to their ability to delay progression of this slow-growing malignancy.

Chemotherapy-induced peripheral neuropathy is a potentially debilitating, often persistent adverse event associated with taxane-based chemotherapy.

Fred Hutchinson Cancer Center appointed Lawrence Fong, MD, as scientific director of the Immunotherapy Integrated Research Center.

Expansion of the Affordable Care Act significantly increased cancer clinical trial participation among patients with Medicaid insurance, according to study results published in JAMA Oncology.

National Comprehensive Cancer Network’s Oncology Research Program awarded three grants to support research into small cell lung cancer.

Researchers have developed a method to predict which individuals are at higher risk for lung cancer-related mortality.

Cancer clinical trial participation appeared lower among Black and Latinx patients compared with white patients with various cancer types, according to study results published in JAMA Network Open.